DYN Stock Down -31% after 8-Day Loss Streak

DYN: Dyne Therapeutics logo
DYN
Dyne Therapeutics

Dyne Therapeutics (DYN) stock hit day 8 of a continuous streak of days with losses, with cumulative losses over this period amounting to a -30% return. The company has lost about $358 Mil in valuation over the last 8 days, with its current market capitalization being $1.2 Bil. The stock remains 56.9% below its value at the end of 2024. This compares with year-to-date returns of 2.4% for the S&P 500 and -0.8% for the Trefis High Quality Portfolio.

Comparing DYN Stock Returns With The S&P 500

The following table summarizes the return for DYN stock vs. the S&P 500 index over different periods, including the current streak:

Return Period DYN S&P 500
1D -1.6% 1.0%
8D (Current Streak) -31.3% -0.2%
1M (21D) -13.6% 3.1%
3M (63D) -15.9% 6.3%
YTD 2025 -56.9% 2.4%
2024 77.1% 23.3%
2023 14.8% 24.2%
2022 -2.5% -19.4%

Gains and Losses Streaks: S&P 500 Constituents

There are currently 121 S&P constituents with 3 days or more of consecutive gains and 23 constituents with 3 days or more of consecutive losses.

Consecutive Days # of Gainers # of Losers
3D 106 3
4D 6 19
5D 9 1
6D 0 0
7D or more 0 0
Total >=3 D 121 23

Key Financials for Dyne Therapeutics (DYN)

Last 2 Fiscal Years:

Relevant Articles
  1. The Next Big Rally in Ford Motor Stock Could Start Like This
  2. The Risk Factors to Watch Out For in NVIDIA Stock
  3. Intuitive Surgical Stock Now 16% Cheaper, Time To Buy
  4. AT&T Stock Pays Out $85 Bil – Investors Take Note
  5. Intel Stock Pays Out $92 Bil – Investors Take Note
  6. Comcast Stock Capital Return Hits $44 Bil

Metric FY2023 FY2024
Revenues
Operating Income $-242.2 Mil $-343.9 Mil
Net Income $-235.9 Mil $-317.4 Mil

Last 2 Fiscal Quarters:

Metric 2024 FQ4 2025 FQ1
Revenues
Operating Income $-97.1 Mil $-122.4 Mil
Net Income $-89.5 Mil $-115.4 Mil

The losing streak DYN stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.